France and Romania: Comparison of recommended vaccinations
Back to search
Export to spreadsheet
France Romania
    General recommendation
    Recommendation for specific groups only
    Catch-up (e.g. if previous doses missed)
 		 Vaccination not funded by the National Health system
 		 Mandatory vaccination
BirthMonthsYears
23456111216-182561113141517181924252627354564657475≥ 76
RSV
RSV10
RSV11
RSV
Coronavirus disease (COVID-19)1
COVID-19
COVID-1912
COVID-19
tuberculosis
BCG13
BCG14
rotavirus infection
ROTA
ROTA
ROTA15
diphtheria2
D
D
D
D
d
d16
d
d17
D
D
D
D
d
tetanus2
TT
TT
TT
TT
TT
TT16
TT
TT17
TT
TT
TT
TT
TT18
pertussis3
acP19
acP
acP
acP
acp
acp20
acP
acP
acP
acP
acp
acp21
poliomyelitis
IPV
IPV
IPV
IPV
IPV
IPV16
IPV
IPV17
IPV
IPV
IPV
IPV
Haemophilus influenzae type b infection
Hib
Hib
Hib
Hib
Hib
Hib
hepatitis B4
HepB22
HepB
HepB
HepB
HepB23
HepB24
HepB
HepB
HepB
pneumococcal disease56
PCV13 or PCV15
PCV13 or PCV1525
PCV13 or PCV15
PCV13 or PCV15
PCV20 or PCV21
PCV20 or PCV21
PCV13
PCV13
PCV13
PCV13/PCV15 + PPSV23 or PCV20
PCV13 or PCV15 or PCV20 or PPSV23
meningococcal disease7
MenB26
MenB
MCV427
MCV4/MenB
MCV428
MCV4/MenB
measles8
MEAS29
MEAS
MEAS
MEAS30
MEAS31
MEAS
MEAS
mumps8
MUMPS
MUMPS
MUMPS30
MUMPS31
MUMPS
MUMPS
rubella8
RUBE
RUBE
RUBE30
RUBE32
RUBE
RUBE
human papillomavirus infection
HPV9 (F/M)33
HPV9 (F/M)34
HPV9 (F/M)
HPV9(F)
influenza9
IIV4
IIV4
IIV3/IIV4/LAIV
IIV3/IIV4/QIV-HD35
herpes zoster
ZOS36
ZOS36

Footnotes:

  1. https://sante.gouv.fr/prevention-en-sante/preserver-sa-sante/vaccination/calendrier-vaccinal, An additional dose of vaccine is recommended in the spring for people aged 80 and over, immunocompromised individuals regardless of age, residents of nursing homes and long-term care facilities, and anyone at very high risk.
  2. Risk group vaccination of dT for pregnant women. dTap is also recommended and reimbursed as a booster every 10 years from the previous dose in adults and to bone marrow transplant recipients and their family contacts who do not have specific detectable antibodies.
  3. dTap is also recommended and reimbursed as a booster every 10 years from the previous dose in adults and to bone marrow transplant recipients and their family contacts who do not have specific detectable antibodies.
  4. Recommended and reimbursed for: dialysis patients who were unvaccinated before 1995 and chronic dialysis patients who require booster doses documented serologically; people with HIV infection; people with organ, tissue, or human cell transplants; people who benefit from immunosuppressive therapy; direct contacts of confirmed hepatitis B cases; people with chronic liver diseases; asplenia; unvaccinated medical and healthcare specialist staff and healthcare auxiliary staff.
  5. August 2023: Updated recommendations for pneumococcal vaccination published including policies on continued vaccination for those previously vaccinated with PCV13 and/or PPSV23 see https://www.has-sante.fr/jcms/p_3457419/fr/strategie-de-vaccination-contre-les-infections-a-pneumocoque-place-du-vaccin-pneumococcique-polyosidique-conjugue-20-valent-adsorbe-chez-l-adulte
  6. Recommended and reimbursed for: children under 19 years old, born before 1 October 2017; people aged between 19 and 65 years, suffering of asplenia, chronic diseases or immunosuppressive diseases and specialized medical and healthcare personnel and auxiliary medical staff.
  7. MenB/MenC/MenACYW vaccination: Recommendations for specific at-risk groups apply - refer to the national immunisation policy document for further information (link provided below)
  8. Contacts from outbreaks of measles, mumps, rubella and flue, regardless of age. Is also recommended and reimbursed for bone marrow transplant recipients and their family contacts who do not have specific detectable antibodies.
  9. For risk groups established by the World Health Organization. Also recommended and reimbursed for specialized medical and healthcare personnel and auxiliary medical staff. IIV is also recommended during pregnancy.
  10. The vaccine is offered to pregnant women between gestational weeks 32 and 36 as part of a combined strategy with monoclonal antibodies. It is typically administered as a single-dose program during the autumn and winter seasons.
  11. Vaccine offered only to patients with risk factors.
  12. More information https://professionnels.vaccination-info-service.fr/Toutes-les-actualites/Campagne-de-vaccination-contre-le-Covid-19-en-automne-2025
  13. Only recommended for children at high-risk of tuberculosis. Please refer to original document for detailled information on risk-groups.
  14. Administration during the 2-7 days after delivery
  15. 3rd dose only for pentavalent rotavirus vaccines
  16. dTacp-IPV or dTT-IPV if last dTacp-IPV received in the previous 5 years
  17. dTT-IPV every 10 years from 65 years of age
  18. booster every 10 years from the previous dose in adults
  19. or 8 weeks of age
  20. For those who did not receive a dose of pertussis containing vaccine during the past 5 years, a booster with a quadrivalent vaccine (dTacp-IPV) is recommended at the time of the Td-IPV booster at 25 years. For those aged 25 years and above that did not receive a booster dose, catch-up with a dTacp-IPV vaccine can be proposed until 39 years of age. Recommendation to have an interval of 10 years in adults between a documented pertussis and pertussis re-vaccination. Vaccination offered to pregnant women from 2nd trimester and preferably between 20 and 36 weeks of pregnancy. More information available at: calendrier_vaccinal_maj-juin23.pdf (sante.gouv.fr)
  21. Vaccination during pregnancy
  22. Babies born to a mother infected with hepatitis B will be offered a first dose at birth simultaneously with HB immunoglobulin, one month of age and 6 month of age. Four doses scheme (0-1-2-6 months) for premature <32 weeks or less than 2 kg. This intervention shall be evaluated at 9 month of age through HBs Ag and anti-HBs antibodies testing, preferably one to four month after the last vaccine dose.
  23. Three doses in a 0, 1, 6 month schedule. From 11 to 15 years, 2 doses in a 0, 6 schedule
  24. Within 24 hours after birth. In the event that the vaccine against Hepatitis B is not available, a different schedule applies for babies born of HBsAG positive mothers. More information available at: http://www.cnscbt.ro/index.php/calendarul-national-de-vaccinare
  25. For premature infants.
  26. Vaccination introduced in 2022. Mandatory since January 2025.
  27. Introduced in January 2025 in replacement of monovalent MenC
  28. More information available at: https://www.service-public.fr/particuliers/actualites/A16520
  29. https://sante.gouv.fr/prevention-en-sante/preserver-sa-sante/vaccination/calendrier-vaccinal The vaccination from 9 months of age of children entering day care was suspended. Updated recommendations - Measles vaccination for infants under 12 months of age - travelling to countries of high measles endemicity or countries with no measles elimination programmes or in case of exposure to measles cases - One dose of monovalent measles vaccines for infants aged 6 to 8 months. Thereafter 2 doses of MMR as per national recommendations. - Trivalent vaccine can be used for infants aged 9 to 11 months. Thereafter 1 dose of MMR between 12 and 15 month. of MMR are recommended as per national recommendations. In case of exposure to measles cases, administration should occur within 72 hours after exposure to the index case.
  30. 2 doses of MMR one month appart if no previous vaccination ; 1 dose if only one dose previously
  31. Two MMR doses in total among individuals born from 1980
  32. Two MMR doses in total among individuals born from 1980. For rubella, one dose of MMR among unvaccinated woman.
  33. The extension of HPV vaccination to boys aged 11 to 14 with catch-up vaccination for those aged between 15 and 19. This recommendation is applicable since January 1, 2021.
  34. Girls and boy catch-up vaccination recommended with a three-dose schedule at 0, 1-2 and 6 months
  35. For adults aged 45–65 years without chronic medical conditions, the influenza vaccines are 50% reimbursed. For those aged 65 years and above the vaccine is fully reimbursed.
  36. Recommended for adults 18-64 years with certain risk conditions (immunodepressed). Two doses with a minimal interval of 2 months between doses. Vaccination with the inactivated herpes zoster subunit vaccine. for further information, please refert to https://sante.gouv.fr/prevention-en-sante/preserver-sa-sante/vaccination/calendrier-vaccinal